Medexus Pharmaceuticals Inc (MEDXF) (Q2 2027) Earnings Call Highlights: GRAFAPEX Momentum ...
Medexus Pharmaceuticals Inc (MEDXF) posted $29.1 million in fiscal Q2 2027 revenue and $0.8 million net income as GRAFAPEX patient demand surged 156% year-over-year, with management eyeing ASH data Related Stocks: MEDXF ,